Icatibant

Icatibant (brand name Firazyr) is a medicine used to treat acute attacks of hereditary angioedema (HAE). It is a bradykinin B2 receptor antagonist, which works by blocking the action of bradykinin, a chemical in the body that causes swelling. Icatibant is given as a subcutaneous injection, and its effects last for up to 24 hours. It is used to treat HAE attacks in adults and adolescents aged 12 years and older.

Icatibant, sold under the brand name Firazyr, is a medication used to treat sudden attacks of a specific inherited condition known as hereditary angioedema (HAE) . Here's a closer look at its function:

Condition Treated:

• Hereditary Angioedema (HAE): This is a rare genetic disorder that causes episodes of swelling in various body parts, including the face, lips, tongue, throat, abdomen, arms, and legs. The swelling is caused by the lack of a functional protein called C1 inhibitor, leading to uncontrolled production of bradykinin, a substance that triggers inflammation and swelling.

How Icatibant Works:

• Bradykinin B2 Receptor Antagonist: Icatibant belongs to a class of drugs called bradykinin B2 receptor antagonists. It works by specifically blocking the action of bradykinin at the B2 receptors. By doing this, it prevents bradykinin from causing inflammation and swelling in the body.

Benefits of Icatibant:

• Fast-Acting Relief: Icatibant offers rapid relief from the symptoms of an HAE attack, typically within an hour of administration. This can be crucial in situations where swelling affects the airway and breathing difficulties arise.
• Targeted Therapy: Icatibant acts specifically on the B2 receptors involved in the swelling process, minimizing side effects on other bodily functions.

Administration:

• Subcutaneous Injection: Icatibant comes as a prefilled syringe for subcutaneous injection (under the skin) in the abdomen. Patients can be trained to self-administer it during an HAE attack.

Important Considerations:

• Not a Cure: Icatibant treats the acute symptoms of an HAE attack but doesn't cure the underlying condition.
• Multiple Doses: In some cases, a second dose of Icatibant might be needed after 6 hours if symptoms persist or return. However, it shouldn't be used more than three times within 24 hours.
• Doctor's Prescription: Icatibant is a prescription medication, and using it requires a doctor's guidance and supervision.

Additional Notes:

• Icatibant is a valuable tool for managing HAE attacks and improving quality of life for people with this condition.
• If you have any questions or concerns about Icatibant or HAE, talking to your doctor is essential. They can provide more specific information based on your individual situation.